Aldeyra Therapeutics, Inc.
ALDX· Nasdaq
ALDXAldeyra Therapeutics, Inc.
Filed Mar 30, 2016 · 10-K · 90 days after period end · 0001193125-16-523952
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|
| Net Income | -$4.36M | -$2.44M | $9.30M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aldeyra Therapeutics, Inc. · CIK 1341235 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 30, 2016 · 90 d after period end
